![]() |
CAS No. : | 1369761-01-2 |
Cat. No. : | A356094 | |
Formula : | C20H28ClN7O3S | |
Purity : | 98% | |
M.W : | 482.0 g/mol | |
Synonyms : |
1. Cerdulatinib Hydrochloride |
|
MDL No. : | MFCD28348366 | |
Storage : | Keep in dark place, inert atmosphere, room temperature | |
InChI Key : | N/A | |
Pubchem ID : | 56960607 | |
Linear Structure Formula : | - | |
Boiling Point : | - |
Safety of [ 1369761-01-2 ] | |||
---|---|---|---|
Signal Word : | Warning | Class : | N/A |
Precautionary Statements : | P261-P305+P351+P338 | UN# : | N/A |
Hazard Statements : | H302-H315-H319-H335 | Packing Group : | N/A |
GHS Pictogram : |
![]() |
Biological Activity of [ 1369761-01-2 ] | |
---|---|
Description : |
Cerdulatinib hydrochloride (PRT062070) is a selective, orally bioavailable, and reversible ATP-competitive inhibitor targeting both SYK and JAK kinases, with IC50 values of 32 nM for SYK, and impressively low IC50s of 0.5 nM, 12 nM, 6 nM, and 8 nM for Tyk2, JAK1, JAK2, and JAK3, respectively. This dual inhibition profile positions cerdulatinib hydrochloride as a promising candidate for the study of autoimmune diseases and B-cell malignancies[1].[2].
Show More |